About Caradon Therapeutics
Caradon Therapeutics is a private company based in Encinitas, California, incorporated in 2023 in Delaware. It has reported $559,328 raised in one offering on Form D since February 2026. Its chief executive is Brian Johnson.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 8, 2026 | Feb 3, 2026 | $559,328of $900K target | 7 | $79,904 | Options, Securities on exerciseRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Caradon Therapeutics's Form D filed Feb 3, 2026.
BJ
Brian Johnson
Chief Executive Officer and director
Also an executive officer and director at Antlia Bioscience.